// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany

A Dignass - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Entyvio

Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and Germany

B Gorsh - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

N/A

Burden of disease in patients with Crohn’s disease: retrospective analysis of cross-sectional survey data from the USA and Germany

M Bracher - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

N/A

Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis

A Dignass - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

Entyvio

Multi-omics analysis suggests an active role of fungi in Crohn’s disease

A Frau - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

N/A

Interventions for managing fatigue in inflammatory bowel disease: A Cochrane systematic review

D Farrell - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

N/A

Living with and managing symptoms of fatigue, pain and urgency in IBD: an exploratory qualitative study

L Dibley - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)

S Sider - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

Adalimumab

Audit into initial response to vedolizumab infusions for IBD

G Lloyd-Ford - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Entyvio

Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series

R Buckingham - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

Entyvio

Can post biologic infusion monitoring be reduced? A mulit-centred retrospective study

L Younge - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

‘It’s about willpower in the end. You’ve got to keep going’: a qualitative study exploring the experience of pain in inflammatory bowel disease

L Sweeney - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

N/A

Real-world experience: Treatment of iron deficiency anaemia (IDA) with intravenous (IV) iron in inflammatory bowel disease

J Kearns - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

Iron isomaltoside

Microscopic colitis in two DGH, is there a clear pathway to diagnosis or treatment

P Avery - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Microscopic colitis

N/A

The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts

R Campbell - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis

Stefan Schreiber - European Crohn’s and Colitis Organisation (ECCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Entyvio

LEVELS OF MILK ALLERGEN IN BAKED ORAL FOOD CHALLENGE MATERIALS

Sivasankar Baalasubramanian - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Casein

ASCIA TRANSPLANTATION AND PRIMARY IMMUNODEFICIENCY (TAPID) PROJECT

Theresa Cole - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

NEXT GENERATION TREC ANALYSIS TO QUANTIFY T‐CELL PROLIFERATION IN HEALTH, DISEASE AND NEONATAL SCREENING FOR IMMUNODEFICIENCIES

Ruud H. J. Verstegen - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HOW WELL DO PARENTS UNDERSTAND PAEDIATrIC ALLERGIC RHINITIS? LESSONS LEARNT FROM A SURVEY OF THE BURDEN, MYTHS, MISCONCEPTIONS AND MANAGEMENT PRACTICES IN AUSTRALIAN CHILDREN

Sinthia Bosnic-Anticevich - Australasian Society of Clinical Immunology and Allergy (ASCIA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Allergic rhinitis

N/A

Copyright © 2026. QuantiNova All rights reserved